
Commentary|Articles|August 14, 2023
Unpacking Regenerative Medicines and Start-Up Funding with Luis Alvarez
Author(s)Grant Playter
Luis Alvarez, PhD, founder of Theradaptive, candidly discusses how his regenerative therapy start-up evolved and secured start-up funding.
Advertisement
Luis Alvarez, PhD, is the founder of
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
2
Green Chemistry’s Role in Advancing US Chemical Innovation
3
Next-Generation Modalities Drive New Antibody Discovery
4
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
5




